400-82-0725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 00mg | ￥ žƟȇNJNJ | 2 | > 0 | -- | -- | -- | ￥ žƟȇNJNJ | - + | |
| 250mg | ￥ ŎŎžȇNJNJ | -- | > 0 | -- | ￥ ŎŎžȇNJNJ | - + | |||
| g | ￥ ǂŎȣȇNJNJ | -- | 2 | -- | 2 | ￥ ǂŎȣȇNJNJ | - + | ||
| 5g | ￥ ŎŎNJǂȇNJNJ | -- | -- | -- | -- | 2 | -- | ￥ ŎŎNJǂȇNJNJ | - + |
| 0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 25g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
50.44
[]. Wempe MF, et, al. Developing potent human uric acid transporter (hURAT) inhibitors. J Med Chem. 20 Apr 28;54(8):270-.
[2]. A M Ehrly, et al. [Behavior of muscle tissue oxygen pressure in patients with severe intermittent claudication after oral administration of benzarone]. Med Welt. 98 Mar 4;4(9):27-4.
[]. Emmanuel Tadjuidje, et al. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone. PLoS One. 202;7(4):e4806.
[4]. H E Knehr, et al. [Effect of benzarone on the oxygen consumption and the mechanical activity of vascular smooth muscle]. Arzneimittelforschung. 98;(2):2-4.
[5]. Ho Jung Shin, et al. Interactions of urate transporter URAT in human kidney with uricosuric drugs. Nephrology (Carlton). 20 Feb;6(2):56-62.
H02-H4
P264-P270-P27-P0
05766 现货
￥ ǯžƌȇNJNJ -00mg
29955 货期咨询
04576 货期咨询
￥ ŎNJȣȇNJNJ -g
0049 货期咨询
￥ ȣĨƌȇNJNJ -25mg
45044 货期咨询
6744 货期咨询
￥ žȒNJȇNJNJ -g
45046 货期咨询
￥ ŎžžƟȇNJNJ -0mg
8462 货期咨询
￥ ȣNJNJNJȇNJNJ -5mg
6248 货期咨询
￥ ĨŎŎȇNJNJ -g
2486 货期咨询
沪ICP备709645号
